Your browser doesn't support javascript.
loading
Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients.
Hu, Zhong-Jie; Xu, Jia; Yin, Ji-Ming; Li, Li; Hou, Wei; Zhang, Li-Li; Zhou, Zhen; Yu, Yi-Zhou; Li, Hong-Jun; Feng, Ying-Mei; Jin, Rong-Hua.
Afiliação
  • Hu ZJ; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Xu J; Department of Immunology, Centre for Immunotherapy, Institute of Basic Medical Sciences, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
  • Yin JM; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Li L; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Hou W; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Zhang LL; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Zhou Z; Deepwise AI Lab, Beijing, China.
  • Yu YZ; Deepwise AI Lab, Beijing, China.
  • Li HJ; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Feng YM; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Jin RH; Beijing Youan Hospital, Capital Medical University, Beijing, China.
Front Immunol ; 11: 585647, 2020.
Article em En | MEDLINE | ID: mdl-33133104

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Fibrose Pulmonar / Interferon gama / Infecções por Coronavirus Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Fibrose Pulmonar / Interferon gama / Infecções por Coronavirus Idioma: En Ano de publicação: 2020 Tipo de documento: Article